Rest Haven-york in York, PA

Rest Haven-york is a medicare and medicaid certified nursing home in York, Pennsylvania. It is located in York county at 1050 South George Street, York, Pennsylvania 17403. You can reach out to the office of Rest Haven-york via phone at (717) 843-9866. This skilled nursing facility has 159 federally certified beds with average occupancy rate of 60.25%. Its legal business name is Hes Inc and has the following ownership type - For Profit - Corporation.

Rest Haven-york (Medicare CCN 395058) is certified by CMS (Centers for Medicare & Medicaid Services) and participates in both medicare and medicaid program. This means if you are part of medicare or medicaid program, you may consider this nursing facility for your medical needs. It was first certified by CMS in 1967 (57 years certified) and the last quality survey was conducted in March, 2021.

Contact Information

Rest Haven-york
1050 South George Street, York, Pennsylvania 17403
(717) 843-9866


Nursing Home Profile

NameRest Haven-york
Location1050 South George Street, York, Pennsylvania
Certified ByMedicare and Medicaid
No. of Certified Beds159
Occupancy Rate60.25%
Medicare ID (CCN)395058
Legal Business NameHes Inc
Ownership TypeFor Profit - Corporation

NPI Associated with this Nursing Home:

Nursing Homes may have multiple NPI numbers. We have found possible NPI number/s associated with Rest Haven-york from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number1346238672
Organization NameHES INC
Doing Business AsREST HAVEN - YORK
Address1050 S George St, York, PA 17403
Phone Number717-843-9866

News Archive

bioTheranostics launches CancerTYPE ID database and KRAS mutational testing

bioTheranostics, a bioMerieux company that discovers, develops and commercializes innovative molecular diagnostic tests in oncology, announces the launch of an expanded tumor-type database for its flagship product, CancerTYPE ID®, and the launch of KRAS mutational testing.

Oral cladribine to be the first oral disease-modifying multiple sclerosis therapy despite receiving RTF letter

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that a recent "refuse to file" (RTF) letter issued by the Food and Drug Administration (FDA) regarding Merck Serono's oral cladribine has heightened the competition between oral cladribine and its primary competitor, Novartis/Mitsubishi Tanabe's FTY-720 (fingolimod), to be the first oral disease-modifying multiple sclerosis therapy to reach the market in the United States.

STED-RICS microscopy method records rapid movements of molecules in live samples

The newly developed STED-RICS microscopy method records rapid movements of molecules in live samples. By combining raster image correlation spectroscopy (RICS) with STED fluorescence microscopy, researchers of Karlsruhe Institute of Technology (KIT) opened up new applications in medical research, e.g. analyzing the dynamics of cell membranes at high protein concentrations.

FDA approves new indication for Tasigna in treatment of rare blood cancer

The U.S. Food and Drug Administration today approved a new indication for Tasigna (nilotinib) for the treatment of a rare blood cancer when it is first diagnosed. The cancer, called Philadelphia chromosome positive chronic phase chronic myeloid leukemia (Ph+ CP-CML), is a slowly progressing blood and bone marrow disease linked to a genetic abnormality.

Read more Medical News

› Verified 4 days ago

Quality Ratings:

Nursing homes vary in the quality of care and services they provide to their residents. The below quality ratings for Rest Haven-york are calculated from three sources - health inspection results, staffing data, and quality measure data. This information gives you an indication of the care Rest Haven-york give to their patients.
Ratings from Surveys (Inspections):
Ratings from Quality Measures:
Ratings from Staffing Data:
Overall Rating:

News Archive

bioTheranostics launches CancerTYPE ID database and KRAS mutational testing

bioTheranostics, a bioMerieux company that discovers, develops and commercializes innovative molecular diagnostic tests in oncology, announces the launch of an expanded tumor-type database for its flagship product, CancerTYPE ID®, and the launch of KRAS mutational testing.

Oral cladribine to be the first oral disease-modifying multiple sclerosis therapy despite receiving RTF letter

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that a recent "refuse to file" (RTF) letter issued by the Food and Drug Administration (FDA) regarding Merck Serono's oral cladribine has heightened the competition between oral cladribine and its primary competitor, Novartis/Mitsubishi Tanabe's FTY-720 (fingolimod), to be the first oral disease-modifying multiple sclerosis therapy to reach the market in the United States.

STED-RICS microscopy method records rapid movements of molecules in live samples

The newly developed STED-RICS microscopy method records rapid movements of molecules in live samples. By combining raster image correlation spectroscopy (RICS) with STED fluorescence microscopy, researchers of Karlsruhe Institute of Technology (KIT) opened up new applications in medical research, e.g. analyzing the dynamics of cell membranes at high protein concentrations.

FDA approves new indication for Tasigna in treatment of rare blood cancer

The U.S. Food and Drug Administration today approved a new indication for Tasigna (nilotinib) for the treatment of a rare blood cancer when it is first diagnosed. The cancer, called Philadelphia chromosome positive chronic phase chronic myeloid leukemia (Ph+ CP-CML), is a slowly progressing blood and bone marrow disease linked to a genetic abnormality.

Read more Medical News

› Verified 4 days ago

Complaints, Fines and Penalties:

Number of Facility Reported Incidents0
Number of Substantiated Complaints0
Number of Fines0
Total Amount of Fines in Dollars$0
Number of Payment Denials0
Total Number of Penalties0

Patients' Stay Experience:

The resident survey data of Rest Haven-york is compared against the national average with the color code indicators: Better than National Average Worse than National Average

Experience MeasureProviderNational Avg.
Percentage of long-stay residents whose need for help with daily activities has increased7.3714.46
Percentage of long-stay residents who lose too much weight9.195.51
Percentage of low risk long-stay residents who lose control of their bowels or bladder69.0548.41
Percentage of long-stay residents with a catheter inserted and left in their bladder1.341.79
Percentage of long-stay residents with a urinary tract infection1.282.65
Percentage of long-stay residents who have depressive symptoms8.625.05
Percentage of long-stay residents who were physically restrained00.23
Percentage of long-stay residents experiencing one or more falls with major injury1.773.36
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine96.9793.87
Percentage of long-stay residents who received an antipsychotic medication14.7514.2
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine76.2483.88
Percentage of short-stay residents who newly received an antipsychotic medication1.041.79
Percentage of long-stay residents whose ability to move independently worsened29.7417.09
Percentage of long-stay residents who received an antianxiety or hypnotic medication16.2719.7
Percentage of high risk long-stay residents with pressure ulcers6.597.32
Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine98.2195.98
Percentage of short-stay residents who made improvements in function63.8467.99
Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine82.4382.93

News Archive

bioTheranostics launches CancerTYPE ID database and KRAS mutational testing

bioTheranostics, a bioMerieux company that discovers, develops and commercializes innovative molecular diagnostic tests in oncology, announces the launch of an expanded tumor-type database for its flagship product, CancerTYPE ID®, and the launch of KRAS mutational testing.

Oral cladribine to be the first oral disease-modifying multiple sclerosis therapy despite receiving RTF letter

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that a recent "refuse to file" (RTF) letter issued by the Food and Drug Administration (FDA) regarding Merck Serono's oral cladribine has heightened the competition between oral cladribine and its primary competitor, Novartis/Mitsubishi Tanabe's FTY-720 (fingolimod), to be the first oral disease-modifying multiple sclerosis therapy to reach the market in the United States.

STED-RICS microscopy method records rapid movements of molecules in live samples

The newly developed STED-RICS microscopy method records rapid movements of molecules in live samples. By combining raster image correlation spectroscopy (RICS) with STED fluorescence microscopy, researchers of Karlsruhe Institute of Technology (KIT) opened up new applications in medical research, e.g. analyzing the dynamics of cell membranes at high protein concentrations.

FDA approves new indication for Tasigna in treatment of rare blood cancer

The U.S. Food and Drug Administration today approved a new indication for Tasigna (nilotinib) for the treatment of a rare blood cancer when it is first diagnosed. The cancer, called Philadelphia chromosome positive chronic phase chronic myeloid leukemia (Ph+ CP-CML), is a slowly progressing blood and bone marrow disease linked to a genetic abnormality.

Read more News

› Verified 4 days ago


Nursing Homes in York, PA

Promedica Skilled Nrsg And Rehab (kingston Court)
Location: 2400 Kingston Court, York, Pennsylvania 17402
Phone: (717) 755-8811    
Rest Haven-york
Location: 1050 South George Street, York, Pennsylvania 17403
Phone: (717) 843-9866    
Colonial Manor Nursing Home
Location: 970 Colonial Avenue, York, Pennsylvania 17403
Phone: (717) 845-2661    
Pleasant Acres Rehabilitation And Nursing Center
Location: 118 Pleasant Acres Rd,rd7, York, Pennsylvania 17402
Phone: (717) 840-7100    
Promedica Skilled Nrsg And Rehab (york South)
Location: 200 Pauline Drive, York, Pennsylvania 17402
Phone: (717) 741-0824    
Promedica Skilled Nrsg And Rehab (york North)
Location: 1770 Barley Road, York, Pennsylvania 17408
Phone: (717) 767-6530    

Nursing Home

A nursing home (also called skilled nursing facility) is a facility or distinct part of an institution whose primary function is to provide medical, continuous nursing, and other health and social services to patients who are not in an acute phase of illness requiring services in a hospital, but who require primary restorative or skilled nursing services on an inpatient basis above the level of intermediate or custodial care in order to reach a degree of body functioning to permit self care in essential daily living.

A skilled nursing facility (SNF) may be a freestanding facility or part of a hospital that has been certified by Medicare to admit patients requiring subacute care and rehabilitation.

Nursing Home Compare

Nursing Home Compare allows consumers to compare information about nursing homes. It contains quality of care and staffing information for all 15,000 plus Medicare- and Medicaid-participating nursing homes.

Note: Nursing homes aren't included on Nursing Home Compare if they aren't Medicare or Medicaid certified. These Nursing Homes can be licensed by the state.

Information on Nursing Home Compare isn't an endorsement or advertisement for any nursing home and should be considered carefully. Use it with other information you gather about nursing homes facilities. Talk to your doctor or other health care provider about the information on Nursing Home Compare.

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.